Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
Peter Dietrich et al, 2018, Gut CrossRef
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Ho Yeong Lim et al, 2018, Clinical Cancer Research CrossRef
Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure
Hadeer Abosalem et al, 2021, Current Cancer Drug Targets CrossRef
Fight of Turkish medical oncologists against cancer: Focus on two societies: Turkish Society of Medical Oncology and Turkish Oncology Group
Huseyin Abali et al, 2017, Journal of Oncological Sciences CrossRef
Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling
Shovik S. Patel et al, 2021, Frontiers in Genetics CrossRef
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
Jun Ho Ji et al, 2023, International Journal of Molecular Sciences CrossRef
Isoliquiritin Ameliorates Ulcerative Colitis in Rats through Caspase 3/HMGB1/TLR4 Dependent Signaling Pathway
Zhiwei Miao et al, 2024, Current Gene Therapy CrossRef
Cholangiocarcinoma Therapeutics: An Update
Mai Ly Thi Nguyen et al, 2021, Current Cancer Drug Targets CrossRef
KRAS Hijacks the miRNA Regulatory Pathway in Cancer
Angelina S. Bortoletto et al, 2023, Cancer Research CrossRef
RAS-mediated oncogenic signaling pathways in human malignancies
Abdul Q. Khan et al, 2019, Seminars in Cancer Biology CrossRef
Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice
Hao-Jun Xiong et al, 2023, Military Medical Research CrossRef
Effect of Lipopolysaccharides on Liver Tumor Metastasis of twist1a/krasV12 Double Transgenic Zebrafish
Jeng-Wei Lu et al, 2022, Biomedicines CrossRef